317 related articles for article (PubMed ID: 11966406)
21. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
Coulthard SA; Matheson EC; Hall AG; Hogarth LA
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1385-91. PubMed ID: 15571264
[TBL] [Abstract][Full Text] [Related]
22. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.
Clunie GP; Lennard L
Rheumatology (Oxford); 2004 Jan; 43(1):13-8. PubMed ID: 14566029
[TBL] [Abstract][Full Text] [Related]
23. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population.
Milek M; Murn J; Jaksic Z; Lukac Bajalo J; Jazbec J; Mlinaric Rascan I
Pharmacology; 2006; 77(3):105-14. PubMed ID: 16691038
[TBL] [Abstract][Full Text] [Related]
24. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
Song DK; Zhao J; Zhang LR
J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.
Krynetski EY; Tai HL; Yates CR; Fessing MY; Loennechen T; Schuetz JD; Relling MV; Evans WE
Pharmacogenetics; 1996 Aug; 6(4):279-90. PubMed ID: 8873214
[TBL] [Abstract][Full Text] [Related]
26. Development of a rapid clinical TPMT genotyping assay.
Burchard PR; Abou Tayoun AN; Lefferts JA; Lewis LD; Tsongalis GJ; Cervinski MA
Clin Biochem; 2014 Oct; 47(15):126-9. PubMed ID: 25093923
[TBL] [Abstract][Full Text] [Related]
27. Establishment of thiopurine S-methyltransferase gene knockdown in jurkat T-lymphocytes: an in vitro model of TPMT polymorphism.
Misdaq M; Andag R; Oellerich M; Asif AR; von Ahsen N
Ther Drug Monit; 2012 Oct; 34(5):584-92. PubMed ID: 22972540
[TBL] [Abstract][Full Text] [Related]
28. Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis.
Spire-Vayron de la Moureyre C; Debuysère H; Sabbagh N; Marez D; Vinner E; Chevalier ED; Lo Guidice JM; Broly F
Hum Mutat; 1998; 12(3):177-85. PubMed ID: 9711875
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm.
Krynetski EY; Evans WE
Pharm Res; 1999 Mar; 16(3):342-9. PubMed ID: 10213363
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden.
Zimdahl Kahlin A; Helander S; Skoglund K; Söderkvist P; Mårtensson LG; Appell ML
Biochem Pharmacol; 2019 Jun; 164():263-272. PubMed ID: 31005613
[TBL] [Abstract][Full Text] [Related]
31. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
Relling MV; Gardner EE; Sandborn WJ; Schmiegelow K; Pui CH; Yee SW; Stein CM; Carrillo M; Evans WE; Klein TE;
Clin Pharmacol Ther; 2011 Mar; 89(3):387-91. PubMed ID: 21270794
[TBL] [Abstract][Full Text] [Related]
32. Normal thiopurine methyltransferase phenotype testing in a Crohn disease patient with azathioprine induced myelosuppression.
Leung M; Piatkov I; Rochester C; Boyages SC; Leong RW
Intern Med J; 2009 Feb; 39(2):121-6. PubMed ID: 19356188
[TBL] [Abstract][Full Text] [Related]
33. Thiopurine S-methyltransferase pharmacogenetics in childhood acute lymphoblastic leukemia.
Yang JJ; Bhojwani D
Methods Mol Biol; 2013; 999():273-84. PubMed ID: 23666706
[TBL] [Abstract][Full Text] [Related]
34. [Thiopurine S-methyltransferase gene polymorphism in Chilean blood donors].
Alvarez L L; Venegas S M; Larrondo L M; Becerra B N; Castro L A; Quera P R
Rev Med Chil; 2009 Feb; 137(2):185-92. PubMed ID: 19543639
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphism of thiopurine S-methyltransferase in Argentina.
Laróvere LE; de Kremer RD; Lambooy LH; De Abreu RA
Ann Clin Biochem; 2003 Jul; 40(Pt 4):388-93. PubMed ID: 12880540
[TBL] [Abstract][Full Text] [Related]
36. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.
Tumer TB; Ulusoy G; Adali O; Sahin G; Gozdasoglu S; Arinç E
Am J Hematol; 2007 Oct; 82(10):906-10. PubMed ID: 17617792
[TBL] [Abstract][Full Text] [Related]
37. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
38. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.
Weinshilboum R
Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):601-5. PubMed ID: 11259360
[TBL] [Abstract][Full Text] [Related]
39. Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia.
Hongeng S; Sasanakul W; Chuansumrit A; Pakakasama S; Chattananon A; Hathirat P
Med Pediatr Oncol; 2000 Oct; 35(4):410-4. PubMed ID: 11025471
[TBL] [Abstract][Full Text] [Related]
40. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
Boonsrirat U; Angsuthum S; Vannaprasaht S; Kongpunvijit J; Hirankarn N; Tassaneeyakul W; Avihingsanon Y
Lupus; 2008 Feb; 17(2):132-4. PubMed ID: 18250137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]